Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FQAAM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,083.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $2,083.08, was awarded on October 22, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The Defense Logistics Agency, through its Medical Supply Chain division, issued this firm fixed-price delivery order without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The order is scheduled for completion by November 13, 2025, and will be performed at the vendor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion, multi-year contract awarded on November 13, 2025, designed to serve as a critical pharmaceutical supplier for Department of Defense healthcare operations globally. The broader PPV-G GEN V acquisition strategy, valued at $30.3 billion, establishes multiple regional prime vendor contractors to supply branded and generic prescription medications, biologics, over-the-counter drugs, vaccines, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous recent delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FQAAM?
SPE2DB26FQAAM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FQAAM worth?
The government has obligated $2,083 on SPE2DB26FQAAM.
Is contract SPE2DB26FQAAM an order under another contract?
Yes. SPE2DB26FQAAM is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB26FQAAM competed?
The extent of competition for SPE2DB26FQAAM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award